Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645015 | 1.00 | CASP3 (0.42) | CASP3ALDH1A1CASP1CYP3A4CPB1 | |
| SCHEMBL645620 | 1.00 | CASP3 (0.42) | CASP3ALDH1A1CASP1CYP3A4CPB1 | |
| SCHEMBL312812 | 1.00 | CASP3 (0.42) | CASP3ALDH1A1CASP1CYP3A4CPB1 | |
| SCHEMBL644882 | 1.00 | CASP3 (0.42) | CASP3ALDH1A1CASP1CYP3A4CPB1 | |
| SCHEMBL951650 | 1.00 | CASP3 (0.42) | CASP3ALDH1A1CASP1CYP3A4CPB1 | |
| SCHEMBL648174 | 0.89 | MEN1 (0.40) | CASP3ALDH1A1CYP3A4 | |
| SCHEMBL3470575 | 0.89 | CASP1 (0.41) | CASP1 | |
| SCHEMBL648173 | 0.89 | MEN1 (0.40) | CASP3ALDH1A1CYP3A4 | |
| SCHEMBL3470337 | 0.89 | MEN1 (0.40) | CASP3ALDH1A1CYP3A4 | |
| SCHEMBL3470211 | 0.87 | NAAA (0.42) | CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143436-A1 | Inhibitors of interleukin-1beta converting enzyme | VERTEX PHARMACEUTICALS INCORPORATED | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143436-A1 | Inhibitors of interleukin-1beta converting enzyme | IL1A, IL1B, IFNAR1 | CASP3 73/4885ALDH1A1 458/4885CASP1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.